ScreenerHero

IPN Ipsen S.A.

EPA · FR · Healthcare · Drug Manufacturers - Specialty & Generic · ipsen.com
140.60EUR+0.72%Mkt Cap: 12.60B $P/E: 22.75

Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally. It engages in the development of Soma…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8
SFZN
Siegfried Holding AG
$3.47BUSDP/E 17.7

Key Statistics

Company
Market Cap12.60B USD
Enterprise Value11.41B USD
Revenue (TTM)4.66B USD
Gross Profit3.45B USD
Net Income (TTM)482.07M USD
Revenue/Share51.99 EUR
Last Price140.60 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5.5K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)22.75
P/E (Forward)10.03
PEG0.48
EV/EBITDA7.03
EV/Revenue2.45
P/S2.68
P/B2.44
EPS (TTM)6.18
EPS (Forward)13.92
52W Range
112.7046% of range174.00
52W High174.00 EUR
52W Low112.70 EUR
Profitability
Gross Margin80.89%
Oper. Margin28.49%
EBITDA Margin34.80%
Profit Margin11.29%
ROE10.23%
ROA6.39%
Growth
Revenue Growth18.70%
Earnings Growth21.50%
Cash Flow & Leverage
Operating CF1.24B USD
CapEx (TTM)357.28M USD
FCF Margin24.09%
FCF Yield8.92%
Net Debt-1.10B USD
Net Debt/EBITDA-0.68
Balance Sheet
Debt/Equity0.20
Current Ratio1.97
Quick Ratio1.77
Book Value/Sh57.15 EUR
Cash/Share23.91 EUR
Dividends
Fwd Div Rate1.60 EUR
Trail. Div Rate1.60 EUR
Div. Yield1.15%
5Y Avg Yield1.09%
Payout Ratio25.89%
Ex-Div DateJun 3, 2026
Pay Date—
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)165.07 EUR
Upside (mean)+17.4%
Target Range130.00 EUR – 235.00 EUR
130.00+17.4% to mean235.00
# Analysts15
Ownership
Shares Out.82.45M
Float29.97M
Insiders57.64%
Institutions21.73%
Technical
SMA 50157.83 (-10.9%)
SMA 200154.81 (-9.2%)
Beta0.32
S&P 52W Chg14.58%
Avg Vol (30d)97.45K
Avg Vol (10d)122.53K
Technical Indicators
RSI (14)27.0
MACD-5.5014
MACD Signal-4.1991
MACD Hist.-1.3022
BB Upper166.98 EUR
BB Middle151.64 EUR
BB Lower136.29 EUR
BB Width20.24%
ATR (14)3.993 EUR
Vol Ratio (20d)0.93x